Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) and LMP2A function cooperatively to promote carcinoma development in a mouse carcinogenesis model

Journal of Virology

Volumn 86, Issue 9, 2012, Pages 5352-5365

  Shair, Kathy H Y ^a   Bendt, Katharine M ^a   Edwards, Rachel H ^a   Nielsen, Judith N ^b   Moore, Dominic T ^a   Raab Traub, Nancy ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2A; MITOGEN ACTIVATED PROTEIN KINASE; STAT3 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER MODEL; CARCINOGENESIS; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVATION; EPSTEIN BARR VIRUS; GENE MUTATION; GENOTYPE; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; ONCOGENE H RAS; PAPILLOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CARCINOMA; CELL TRANSFORMATION, VIRAL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENE EXPRESSION; GENES, RAS; KERATIN-14; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MUTATION; PAPILLOMA; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4; MUS; MUS MUSCULUS;

EID: 84861312893     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.07035-11     Document Type: Article

References (56)

1. Balmain A, Pragnell IB. 1983. Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene. Nature 303:72-74.
2. Cahir-McFarland ED, Davidson DM, Schauer SL, Duong J, Kieff E. 2000. NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proc. Natl. Acad. Sci. U. S. A. 97:6055-6060.
3. Caldwell RG, Brown RC, Longnecker R. 2000. Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice. J. Virol. 74:1101-1113.
4. Caldwell RG, Wilson JB, Anderson SJ, Longnecker R. 1998. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9:405-411.
5. Chan KS, et al. 2004. Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis. Cancer Res. 64:2382-2389.
6. Chan KS, et al. 2004. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J. Clin. Invest. 114:720-728.
7. Charalambous CT, Hannigan A, Tsimbouri P, McPhee GM, Wilson JB. 2007. Latent membrane protein 1-induced EGFR signalling is negatively regulated by TGF alpha prior to neoplasia. Carcinogenesis 28:1839-1848.
8. Curran JA, Laverty FS, Campbell D, Macdiarmid J, Wilson JB. 2001. Epstein-Barr virus encoded latent membrane protein-1 induces epithelial cell proliferation and sensitizes transgenic mice to chemical carcinogenesis. Cancer Res. 61:6730-6738.
9. Dawson CW, Laverick L, Morris MA, Tramoutanis G, Young LS. 2008. Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway. J. Virol. 82:3654-3664.
10. Dawson CW, Tramountanis G, Eliopoulos AG, Young LS. 2003. Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling. J. Biol. Chem. 278:3694-3704.
11. Ikeda M, Longnecker R. 2007. Cholesterol is critical for Epstein-Barr virus latent membrane protein 2A trafficking and protein stability. Virology 360:461-468.
12. Ise K, et al. 2000. Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis. Oncogene 19:2951-2956.
13. Kulwichit W, et al. 1998. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 95:11963-11968.
14. Kung CP, Meckes DG, Jr, Raab-Traub N. 2011. Epstein-Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCdelta. J. Virol. 85:4399-4408.
15. Kung CP, Raab-Traub N. 2008. Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3. J. Virol. 82:5486-5493.
16. Lo PH, et al. 2007. Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage. Cancer Lett. 257:199-205.
17. Longan L, Longnecker R. 2000. Epstein-Barr virus latent membrane protein 2A has no growth-altering effects when expressed in differentiating epithelia. J. Gen. Virol. 81:2245-2252.
18. Lu J, et al. 2006. Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells. J. Biol. Chem. 281:8806-8814.
19. Lu J, Rho O, Wilker E, Beltran L, Digiovanni J. 2007. Activation of epidermal akt by diverse mouse skin tumor promoters. Mol. Cancer Res. 5:1342-1352.
20. Luo HR, et al. 2003. Akt as a mediator of cell death. Proc. Natl. Acad. Sci. U. S. A. 100:11712-11717.
21. Macdiarmid J, Stevenson D, Campbell DH, Wilson JB. 2003. The latent membrane protein 1 of Epstein-Barr virus and loss of the INK4a locus: paradoxes resolve to cooperation in carcinogenesis in vivo. Carcinogenesis 24:1209-1218.
22. Mainou BA, Everly DN, Jr, Raab-Traub N. 2005. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. Oncogene 24:6917-6924.
23. Man C, et al. 2007. Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells. Oncogene 26:3069-3080.
24. Matthews JN, Altman DG, Campbell MJ, Royston P. 1990. Analysis of serial measurements in medical research. BMJ 300:230-235.
25. Maufort JP, Williams SM, Pitot HC, Lambert PF. 2007. Human papillomavirus 16 E5 oncogene contributes to two stages of skin carcinogenesis. Cancer Res. 67:6106-6112.
26. Meckes DG, Jr, et al. 2010. Human tumor virus utilizes exosomes for intercellular communication. Proc. Natl. Acad. Sci. U. S. A. 107:20370-20375.
27. Medina EA, et al. 2005. Tumor necrosis factor-{alpha} decreases Akt protein levels in 3T3-L1 adipocytes via the caspase-dependent ubiquitination of Akt. Endocrinology 146:2726-2735.
28. Megosh L, Halpern M, Farkash E, O'Brien TG. 1998. Analysis of ras gene mutational spectra in epidermal papillomas from K6/ODC transgenic mice. Mol. Carcinog. 22:145-149.
29. Miller CL, et al. 1995. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2:155-166.
30. Miller CL, Lee JH, Kieff E, Longnecker R. 1994. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc. Natl. Acad. Sci. U. S. A. 91:772-776.
31. Morris MA, Dawson CW, Young LS. 2009. Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma. Future Oncol. 5:811-825.
32. Morrison JA, Gulley ML, Pathmanathan R, Raab-Traub N. 2004. Differential signaling pathways are activated in the Epstein-Barr virusassociated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma. Cancer Res. 64:5251-5260.
33. Morrison JA, Klingelhutz AJ, Raab-Traub N. 2003. Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells. J. Virol. 77:12276-12284.
34. Pegtel DM, et al. 2005. Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis. J. Virol. 79:15430-15442.
35. Portis T, Longnecker R. 2004. Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway. Oncogene 23:8619-8628.
36. Quintanilla M, Brown K, Ramsden M, Balmain A. 1986. Carcinogenspecific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322:78-80.
37. Raab-Traub N. 2002. Epstein-Barr virus in the pathogenesis of NPC. Semin. Cancer Biol. 12:431-441.
38. Raab-Traub N. 1996. Pathogenesis of Epstein-Barr virus and its associated malignancies. Semin. Virol. 7:315-323.
39. Rehman I, et al. 2000. Frequent codon 12 Ki-ras mutations in mouse skin tumors initiated by N-methyl-N=-nitro-N-nitrosoguanidine and promoted by mezerein. Mol. Carcinog. 27:298-307.
40. Satomi Y, Bu P, Okuda M, Tokuda H, Nishino H. 2003. H-ras mutations at codon 61 or 13 in tumors initiated with aNOdonor in mouse skin. Cancer Lett. 196:17-22.
41. Scholle F, Bendt KM, Raab-Traub N. 2000. Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J. Virol. 74:10681-10689.
42. Segrelles C, et al. 2007. Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis. Cancer Res. 67:10879-10888.
43. Segrelles C, et al. 2002. Functional roles of Akt signaling in mouse skin tumorigenesis. Oncogene 21:53-64.
44. Shair KH, et al. 2007. EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas. PLoS Pathog. 3:e166.
45. Shair KH, Schnegg CI, Raab-Traub N. 2008. EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration. Cancer Res. 68:6997-7005.
46. Shair KH, Schnegg CI, Raab-Traub N. 2009. Epstein-Barr virus latent membrane protein-1 effects on junctional plakoglobin and induction of a cadherin switch. Cancer Res. 69:5734-5742.
47. Song S, Liem A, Miller JA, Lambert PF. 2000. Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis. Virology 267: 141-150.
48. Stevenson D, Charalambous C, Wilson JB. 2005. Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9. Cancer Res. 65:8826-8835.
49. Thornburg NJ, Pathmanathan R, Raab-Traub N. 2003. Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma. Cancer Res. 63:8293-8301.
50. Tsao SW, Tramoutanis G, Dawson CW, Lo AK, Huang DP. 2002. The significance of LMP1 expression in nasopharyngeal carcinoma. Semin. Cancer Biol. 12:473-487.
51. Uchida J, et al. 1999. Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science 286:300-303.
52. Wilson JB, Weinberg W, Johnson R, Yuspa S, Levine AJ. 1990. Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 61:1315-1327.
53. Woodworth CD, et al. 2004. Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte. Carcinogenesis 25:1771-1778.
54. Young LS, Murray PG. 2003. Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 22:5108-5121.
55. Young LS, Rickinson AB. 2004. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4:757-768.
56. Yuspa SH. 1994. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis-thirty-third G. H. A. Clowes Memorial Award Lecture. Cancer Res. 54:1178-1189.